A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants
Clinical trial NCT06092931 · COMPLETED
Trial details
- NCT number
- NCT06092931
- Sponsor
- DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2023-11-28
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.